source
- ‘A two-way conversation with the tumor’: Researchers use ‘avatar’ to predict immunotherapy responsesResearchers have explored a revolutionary way to predict a patient's response to immunotherapies by creating a tumor “avatar” from biopsies.Fierce Biotech · 1d ago↗ source
- Merck KGaA to acquire Silence Therapeutics for $1.3 billion, expanding siRNA portfolioMerck KGaA, the German science and technology conglomerate, announced an agreement to purchase UK‑based Silence Therapeutics. The deal is valued at about $1.3 billion and gives Merck access to Sil…